1-500 | 501-1000 | 1001-1158
     Part,  Chapter, Paragraph

   1    I,     2.  5        |                    working conditions (ILO, 2006).~ ~All these issues can
   2    I,     2.  5        |                    rates. During the period 2006-2007 6.5 million new jobs
   3    I,     2.  5        |                   will continue to grow. By 2006 it had reached the stage
   4    I,     2.  5        |                  Safety and Health at Work, 2006).~Both case studies and
   5    I,     2.  6        |                   Countries, per gender, in 2006.~ ~In the EU25 as a whole,
   6    I,     2.  6        |                points (European Commission, 2006).~While education is primarily
   7    I,     2.  6        |                 level (European Commission, 2006).~ ~Considering the large
   8    I,     2. 10.  2    |                 Royal Society, 2004; NIOSH, 2006; Schulte et al, 2007; Nel
   9    I,     2. 10.  2    |                     et al, 2007; Nel et al, 2006; Medina et al, 2007).~ ~
  10    I,     2. 10.  2    |                    uses include (Nel et al, 2006); (Medina et al, 2007).~ ~-
  11    I,     2. 10.  3    |           outsourcing internationally (ILO, 2006). Moreover, the speed with
  12    I,     2. 10.  3(6) |                International Labour Office (2006): Changing patterns in the
  13    I,     2. 10.  3(6) |                    Conference, 95th Session 2006, Report I (C). ILO, Geneva.~
  14    I,     2. 10.  3    |                  linking European Policies, 2006). From a business perspective,
  15    I,     2. 10.  4(10)|                     2005). Informe. Febrero 2006. Ministerio de Sanidad y
  16    I,     2. 10.  4(10)|                   Sanidad y Consumo, Madrid 2006~
  17    I,     2. 10.  4(11)|                   Ziekenhuizen, 10 November 2006~
  18    I,     2. 10.  4    |                     Internet pharmacies. In 2006, 2.7 million items were
  19    I,     2. 10.  4(13)|                   275Revised 14 November 2006~
  20    I,     2. 10.  4(14)|                    Results at the EU Border 2006”, European Commission, May
  21    I,     2. 10.  4(15)|                   275Revised 14 November 2006~
  22    I,     2. 10.  4(20)|                     Confererence 13-15 June 2006, Minneapolis, Usa~
  23    I,     2. 11        |                  Safety and Health at Work (2006). Research on New Forms
  24    I,     2. 11        |                   06).~European Commission (2006): European Economy. Directorate-general
  25    I,     2. 11        |                affairs. Special Report  1/2006. Available at: htt ~ ~European
  26    I,     2. 11        |                International Labour Office (2006): Changing patterns in the
  27    I,     2. 11        |                    Conference, 95th Session 2006, Report I (C): ILO, Geneva~
  28    I,     2. 11        |                      552-558.~Nel A et al. (2006): Toxic potential of materials
  29    I,     2. 11        |                   vol. 311, 622-627.~NIOSH (2006): NIOSH Safety and Health
  30    I,     3.  2        |                     of the current EU27. In 2006, this percentage diminished
  31    I,     3.  2        |                 Member States. From 1960 to 2006 the overall EU population
  32    I,     3.  2        |               Slovak Republic and Spain. In 2006, only Bulgaria had a lower
  33    I,     3.  2        |             Although, in the EU in the 1960-2006 period the entire yearly
  34    I,     3.  2        |                       Compared to 2000, the 2006 population sizes were smaller
  35    I,     3.  2        |                   per Member State in 1975, 2006 and forecasts for 2050~ ~
  36    I,     3.  2        |                     will be 25% larger than 2006 in Cyprus, Ireland, Luxembourg,
  37    I,     3.  3        |                  Age composition in EU27 in 2006~ ~Figure 3.5. Age composition
  38    I,     3.  3        |                 composition in the NMS12 in 2006~ ~Currently, all European
  39   II,     4.  1        |                   the GALI (van Oyen et al, 2006). The HLY is based on the
  40   II,     4.  1        |             Ministry of Health and Welfare, 2006).5~ ~ ~Table 4.1.5. Life
  41   II,     4.  3        |             Ministry of Health and Welfare (2006): Abridged Life Tables for
  42   II,     4.  3        |                  Health and Human Services (2006): Healthy People 2010 Midcourse
  43   II,     4.  3        |                     van der Heyden, et al. (2006): Monitoring population
  44   II,     5.  2.  1    |                   Luxembourg1 and 2 June 2006; Allender et al, 2008) and
  45   II,     5.  2.  1    |                 increased (Kesteloot et al, 2006). Despite the decline in
  46   II,     5.  2.  2    |                 Kesteloot (Kesteloot et al, 2006). Trends over time have
  47   II,     5.  2.  2    |                      1997; Kesteloot et al, 2006). For the 27 EU member states
  48   II,     5.  2.  3    |                      1997; Kesteloot et al, 2006).~In the 35-74 age-range,
  49   II,     5.  2.  5    |                   CVD risk (Palmieri et al, 2006; Giampaoli et al, 2006;
  50   II,     5.  2.  5    |                      2006; Giampaoli et al, 2006; Hozawa et al, 2007; Daviglus
  51   II,     5.  2.  5    |             non-communicable diseases.~· In 2006, a large conference organised
  52   II,     5.  2.  5    |                  Council of the 30 November 2006 under the Finnish Presidency. (
  53   II,     5.  2.  5    |                     November and 1 December 2006)~· The European Heart Health
  54   II,     5.  2.  6    |               incidence (Robinson JG et al, 2006). The ischemic stroke risk
  55   II,     5.  2.  7    |                     Project Research Group (2006): EUROCISS Project final
  56   II,     5.  2.  7    |                     report 2003 updated May 2006 [htt ] (accessed on 12.07.
  57   II,     5.  2.  7    |             European society of cardiology (2006): 2733 Employment, Social
  58   II,     5.  2.  7    |                   Luxembourg1 and 2 June 2006. European Journal of Cardiovascular
  59   II,     5.  2.  7    |                 Palmieri L, Panico S et al (2006): Favorable cardiovascular
  60   II,     5.  2.  7    |                     Sans S, and Kromhout D (2006): Dynamics of cardiovascular
  61   II,     5.  2.  7    |                      Sega R, and Stamler J (2006): Favorable cardiovascular
  62   II,     5.  3.  1    |                     in EU25 as estimated in 2006.~ ~Table 5.3.1. Estimated
  63   II,     5.  3.  1    |              selected cancer sites in EU25 (2006).~ ~
  64   II,     5.  3.  3    |             European countries for the year 2006 (Ferlay et al, 2007).~-
  65   II,     5.  3.  3    |                  also produced estimates in 2006 (Ferlay et al, 2007). The
  66   II,     5.  3.  3    |                   published by EUROSTAT for 2006. The risk of cancer increases
  67   II,     5.  3.  5    |                 cancer care performance. In 2006, 3,200,000 new cases and
  68   II,     5.  3.  5    |                  highest incidence rates in 2006 were in Western Europe for
  69   II,     5.  3.  5    |                European standard) by sex in 2006 A) Men~Figure 5.3.1b. All
  70   II,     5.  3.  5    |                European standard) by sex in 2006 B) Women~ ~Figure 5.3.2a.
  71   II,     5.  3.  5    |                European standard) by sex in 2006 A) Men~Figure 5.3.3b. All
  72   II,     5.  3.  5    |                European standard) by sex in 2006 B) Women~ ~Figure 5.3.4a.
  73   II,     5.  3.  5    |               Stomach Cancer (ICD-9 151)~In 2006 Europe saw, 160,000 new
  74   II,     5.  3.  5    |                     Ferlay et al, 2007). In 2006 maximum levels of incidence
  75   II,     5.  3.  5    |                European standard) by sex in 2006 A) Men~Figure 5.3.5b. Stomach
  76   II,     5.  3.  5    |                European standard) by sex in 2006 B) Women~ ~Figure 5.3.6a.
  77   II,     5.  3.  5    |                European standard) by sex in 2006 A) Men~Figure 5.3.7b. Stomach
  78   II,     5.  3.  5    |                European standard) by sex in 2006 B) Women~ ~Figure 5.3.8a.
  79   II,     5.  3.  5    |                  Cancer (ICD-9 153, 154)~In 2006, 413,000 new cases and 207,
  80   II,     5.  3.  5    |            countries with a similar GDP. In 2006 Western Europe had maximum
  81   II,     5.  3.  5    |                European standard) by sex in 2006 A) Men~Figure 5.3.9b. Colorectal
  82   II,     5.  3.  5    |                European standard) by sex in 2006 B) Women~ ~Figure 5.3.10a.
  83   II,     5.  3.  5    |                European standard) by sex in 2006 A) Men~Figure 5.3.11b. Colorectal
  84   II,     5.  3.  5    |                European standard) by sex in 2006 B) Women~ ~Figure 5.3.12a.
  85   II,     5.  3.  5    |                  Lung Cancer (ICD-9 162)~In 2006, in Europe there were 386,
  86   II,     5.  3.  5    |            countries with a similar GDP. In 2006 Iceland was the only country
  87   II,     5.  3.  5    |                     macro-areas) for men in 2006 (92 new cases and 85 deaths
  88   II,     5.  3.  5    |                    27 deaths per 100,000 in 2006).~Most European countries
  89   II,     5.  3.  5    |                European standard) by sex in 2006 A) Men~Figure 5.3.13b. Lung
  90   II,     5.  3.  5    |                European standard) by sex in 2006 B) Women~ ~Figure 5.3.14a.
  91   II,     5.  3.  5    |                European standard) by sex in 2006 A) Men~Figure 5.3.15b. Lung
  92   II,     5.  3.  5    |                European standard) by sex in 2006 B) Women~ ~Figure 5.3.16a.
  93   II,     5.  3.  5    |                 cases and 132,000 deaths in 2006 for the entire Europe (Ferlay
  94   II,     5.  3.  5    |                   maximum incidence rate in 2006 was estimated in Belgium (
  95   II,     5.  3.  5    |                rates (European standard) in 2006~Figure 5.3.18. Trends of
  96   II,     5.  3.  5    |                rates (European standard) in 2006~Figure 5.3.20. Trends of
  97   II,     5.  3.  5    |              Prostate Cancer (ICD-9 185)~In 2006, 346,000 new cases and 87,
  98   II,     5.  3.  5    |                rates (European standard) in 2006~Figure 5.3.26. Trends of
  99   II,     5.  3.  5    |                rates (European standard) in 2006~Figure 5.3.28. Trends of
 100   II,     5.  3.  7    |                    performed by ESMO (ESMO, 2006) underlined that in Europe:~·
 101   II,     5.  3.  8    |                     published by the WHO in 2006)~· Diffusion of best practice:
 102   II,     5.  3.  9    |                 suppl 5):v128-v149.~ ~ESMO (2006): Medical Oncology Status
 103   II,     5.  3.  9    |                  and mortality in Europe in 2006. Ann Oncol 18(3):581-592.~ ~
 104   II,     5.  3.  9    |                   on 9th June 2008).~ ~WHO (2006): The European Strategy
 105   II,     5.  4.  1    |                     mmol/l. (Report WHO/IDF 2006). Two major subgroups of
 106   II,     5.  4.  1    |                   third edition (IDF Atlas, 2006) reports 246 millions currently
 107   II,     5.  4.  2    |                      Massi Benedetti et al. 2006) has played a role in proposing
 108   II,     5.  4.  2    |                    in Europe (Carinci et al 2006).~In other cases, registers
 109   II,     5.  4.  2    |        HaemoglobinHbA1c, see Armesto et al. 2006) due to problems in national
 110   II,     5.  4.  2    |                 striking with the IDF Atlas 2006, reporting a range between
 111   II,     5.  4.  2    |                     the OECD (Armesto et al 2006) as fit for international
 112   II,     5.  4.  3    |                  the field by the IDF Atlas 2006 and the core and secondary
 113   II,     5.  4.  3    |                   According to the IDF data 2006, the absolute number of
 114   II,     5.  4.  3    |                 approximately 31 million in 2006 to over 37 million in 2025.
 115   II,     5.  4.  3    |                 over 37 million in 2025. In 2006, approximately 8.7% of the
 116   II,     5.  4.  3    |                    tolerance. The IDF Atlas 2006 reports an average of 9%
 117   II,     5.  4.  3    |                   OECD data (Armesto et al, 2006) show results for 7 EU countries
 118   II,     5.  4.  6    |                      project was started in 2006 “to make the national facts
 119   II,     5.  4.  6    |                    during its Presidency in 2006;~· the European Parliament,
 120   II,     5.  4.  6    |               European Parliament, in April 2006, urged the European Commission
 121   II,     5.  4.  6    |             organized in Vienna in February 2006, were adopted by the formal
 122   II,     5.  4.  6    |               formal Health Council in June 2006 as Diabetes EU policy;~·
 123   II,     5.  4.  6    |              Council of the European Union (2006) endorsed IDF recommendations,
 124   II,     5.  4.  6    |                     in Luxembourg, 1-2 June 2006 (see Table 5.4.1);~ ~Table
 125   II,     5.  4.  6    |                   health threat in December 2006 through the following statements (
 126   II,     5.  4.  8    |                  the HCQI Expert GroupOECD (2006), 2006 Data Collection Update
 127   II,     5.  4.  8    |                    Expert GroupOECD (2006), 2006 Data Collection Update Report,
 128   II,     5.  4.  8    |                 Working Papers No. 29, OECD 2006~Azzopardi J, Fenech FF,
 129   II,     5.  4.  8    |              Council of the European Union (2006), Council Conclusions on
 130   II,     5.  4.  8    |               meeting, Luxembourg, 1-2 June 2006~[http://www.consilium.europa.
 131   II,     5.  4.  8    |                  FEND, IDF European Region (2006):Diabetes: the Policy puzzle.
 132   II,     5.  4.  8    |                     EU25 FEND /IDF - Europe 2006, available at: [http://www.
 133   II,     5.  4.  8    |                Technical Papers NO. 15~IDF (2006), Diabetes Atlas Third Edition.~
 134   II,     5.  4.  8    |               Carinci F, Orsini Federici M (2006), The Umbria Diabetes Register,
 135   II,     5.  4.  8    |               Register, Diab Res Clin Pract 2006; 74:S200-S204.~Morris AD,
 136   II,     5.  4.  8    |                    IDF Consultation Report (2006): Definition and diagnosis
 137   II,     5.  4.  8    |                   World Health Organization 2006 [http://www.who.int/entity/
 138   II,     5.  5.Int(16)|             International Longevity Center (2006): Ageism in America. New
 139   II,     5.  5.Int(17)|                     Jamison DT, Murray CJL (2006): Global Burden of Disease
 140   II,     5.  5.Int    |            consultation period ended in May 2006; in December 2006 the European
 141   II,     5.  5.Int    |                    in May 2006; in December 2006 the European Commission
 142   II,     5.  5.Int(21)|                    covering the period 2002-2006, Decision  1513/2002/EC
 143   II,     5.  5.  1    |             physical illness (Saarni et al, 2006). In addition, depression
 144   II,     5.  5.  1    |                    countries (Sobocki et al 2006). The total costs of depression
 145   II,     5.  5.  1    |               community level (Berk et al., 2006) and genetic factors (Currier
 146   II,     5.  5.  1    |                  women committed suicide in 2006 (Eurostat). This number
 147   II,     5.  5.  1    |                   beds ( Katschhnig ET AL., 2006).~ ~ WHO databases~ ~The
 148   II,     5.  5.  1    |                    Berk M, Dodd S, Henry M (2006). The effect of macroeconomic
 149   II,     5.  5.  1    |                ESEMED/MHEDEA Investigators (2006). Risk factors for suicidality
 150   II,     5.  5.  1    |             International Longevity Center.(2006). Ageism in America. New
 151   II,     5.  5.  1    |                   17(1):14-9.~ ~S H et al. (2006). The impact of 29 chronic
 152   II,     5.  5.  1    |                   Hogrefe and Huber.~ ~S C (2006). Cost of depression in
 153   II,     5.  5.  2    |               dementia (Alzheimer Scotland, 2006).~ ~Dementia tends to progress
 154   II,     5.  5.  2    |                   Turkey (Alzheimer Europe, 2006). The results are as follows:~ ~
 155   II,     5.  5.  2    |              References~ ~Alzheimer Europe (2006): Dementia in Europe Yearbook.
 156   II,     5.  5.  2    |                Europe~ ~Alzheimer Scotland (2006): Good for you – good for
 157   II,     5.  5.  3    |             adolescents and females (Levey, 2006). Levey (2006) notes that
 158   II,     5.  5.  3    |               females (Levey, 2006). Levey (2006) notes that more than 90%
 159   II,     5.  5.  3    |                     as in adulthood (Levey, 2006).~Anorexia as “appetite
 160   II,     5.  5.  3    |                     1002/eat.1022.~Levey R (2006): Anorexia Nervosa. eMedicine.
 161   II,     5.  5.  3    |                further evaluation (McGrath, 2006).~According to the fact
 162   II,     5.  5.  3    |                    rate of diagnosis (Sato, 2006).~ ~The data concerning
 163   II,     5.  5.  3    |                  study (Mathers and Loncar, 2006) describe a positive trend
 164   II,     5.  5.  3    |                 other factors (Healy et al, 2006).~Currently available statistical
 165   II,     5.  5.  3    |                     females (Mathers et al, 2006).~Deficits in social abilities
 166   II,     5.  5.  3    |                      Punnoose and Belgamwar 2006).~The treatment of people
 167   II,     5.  5.  3    |                   side effects (Engl et al, 2006) the increased rate in people
 168   II,     5.  5.  3    |               increased (Häfner and Maurer, 2006).~Effective intervention
 169   II,     5.  5.  3    |                    of symptoms (Bottlender, 2006).~Although a number of prodromal
 170   II,     5.  5.  3    |                 Pitschel-Walz, 2007; Vauth, 2006,; Glynn, 2003; Pilling et
 171   II,     5.  5.  3    |          development process (Leucht et al, 2006; Gaebel et al, 2005; AGREE
 172   II,     5.  5.  3    |               renaming schizophrenia (Sato, 2006). A pilot study recently
 173   II,     5.  5.  3    |                thereby save costs” (Leucht, 2006).~Fighting stigma~Some countries
 174   II,     5.  5.  3    |                     of print.~Bottlender R (2006): For and against: “Every
 175   II,     5.  5.  3    |                    CP, Jones L, Woolson RF (2006): Medical comorbidity in
 176   II,     5.  5.  3    |                   Parsch JR, Ebenbichler C (2006): Antipsychotic drug-induced
 177   II,     5.  5.  3    |                  2007.~European Commission (2006): Report and Recommendations
 178   II,     5.  5.  3    |                      Häfner H and Maurer K (2006): Early detection of schizophrenia:
 179   II,     5.  5.  3    |                Jones-Edwards G, Roberts AP (2006): Lifetime suicide rates
 180   II,     5.  5.  3    |                     Wahlbeck K, Kissling W (2006): Call for a European guidelines
 181   II,     5.  5.  3    |                 1991.~Mathers CD, Loncar D (2006): Projections of Global
 182   II,     5.  5.  3    |                     3(11):e442.~McGrath JJ (2006): Variations in the incidence
 183   II,     5.  5.  3    |                   Punnoose S, Belgamwar MR (2006): Nicotine for schizophrenia.
 184   II,     5.  5.  3    |                   370(9590):810-11.~Sato M (2006): Renaming schizophrenia:
 185   II,     5.  5.  3    |                  333, 2007.~htt df~Vauth R (2006): Psychosocial Interventions
 186   II,     5.  5.  3    |                Finally, at the beginning of 2006 the EAIS project approved
 187   II,     5.  5.  3    |                      2002; Pugliatti et al, 2006; Pugliatti and Rosati, in
 188   II,     5.  5.  3    |                 elsewhere (Pugliatti et al, 2006).~When feasible, the total
 189   II,     5.  5.  3    |             patients in Norway (Myhr et al, 2006; www ). In 2007, a biobank
 190   II,     5.  5.  3    |               Sweden (Brønnum-Hansen et al, 2006) probably indicating a similar
 191   II,     5.  5.  3    |                   and 127 (Pugliatti et al, 2006) and an estimated mean annual
 192   II,     5.  5.  3    |                    Cyprus (Pugliatti et al, 2006), with a mean annual incidence
 193   II,     5.  5.  3    |                  Portugal (Pugliatti et al, 2006), increasing trends in Norway,
 194   II,     5.  5.  3    |                   programmes (Miller et al, 2006). Also, home-based care
 195   II,     5.  5.  3    |                      of the original report 2006 (MSTCG and Rieckmann, 2006)~
 196   II,     5.  5.  3    |                  2006 (MSTCG and Rieckmann, 2006)~Recent clinical studies
 197   II,     5.  5.  3    |             Therapie bei MS”. (Henze et al, 2006).~Although there is a vast
 198   II,     5.  5.  3    |                sclerosis ( Haffenden et al, 2006).~This position paper based
 199   II,     5.  5.  3    |                 Hansen T, Koch-Henriksen H (2006): Survival and mortality
 200   II,     5.  5.  3    |                  Paulos A, Mendes H, et al (2006): The prevalence of multiple
 201   II,     5.  5.  3    |                    the extension phase 2005/2006. Poster presentation at
 202   II,     5.  5.  3    |                 Glad SB, Aarseth JH, et al (2006): A 50-year follow-up of
 203   II,     5.  5.  3    |                Pitschnau-Michel D, Voltz D (2006) Position Paper Palliative
 204   II,     5.  5.  3    |                   Rieckman, P and Toyka KY (2006): Symptomatic Treatment
 205   II,     5.  5.  3    |              Sclerosis Society. Eur Neurol. 2006;56(2):78-105~Horakova D (
 206   II,     5.  5.  3    |                   Noseworthy J, Compston A (2006): Care of the person with
 207   II,     5.  5.  3    |                     group) and Rieckmann P (2006): Escalating immunomodulatory
 208   II,     5.  5.  3    |                    N, Aarseth JH, Nyland H (2006): The Norwegian Multiple
 209   II,     5.  5.  3    |                  Ristic S, Sepcic J, et al (2006): Region with persistent
 210   II,     5.  5.  3    |                  Rosati G, Carton H, et al (2006): The epidemiology of multiple
 211   II,     5.  5.  3    |                 disability (Horstink et al, 2006). This considerably affects
 212   II,     5.  5.  3    |                    al, 2005; Dowding et al, 2006; Lindgren et al, 2005; von
 213   II,     5.  5.  3    |                    implicated (Chade et al, 2006). Fall et al (1999) found
 214   II,     5.  5.  3    |                     Quik, 2004; Chade et al 2006). However, whether this
 215   II,     5.  5.  3    |                    AR, Kasten M, Tanner CM (2006): Nongenetic causes of Parkinson’
 216   II,     5.  5.  3    |                   CH, Shenton CL, Salek SS (2006): A review of the health-related
 217   II,     5.  5.  3    |                     W, Rascol O, Sampaio C (2006): Review of the therapeutic
 218   II,     5.  6.  1    |                   European Strategy for NCD 2006).~ ~
 219   II,     5.  6.  3    |                   European Strategy for NCD 2006) and osteoarthritis is the
 220   II,     5.  6.  3    |                     countries (Lopez et al, 2006).~ ~Health care utilization~ ~
 221   II,     5.  6.  3    |                     burden and risk factors 2006) .~ ~Economic impact is
 222   II,     5.  6.  3    |               mortality (Woolf and Akesson, 2006).~ ~Colle’s fracture results
 223   II,     5.  6.  6    |                   Department of Health, UK (2006): The Musculoskeletal Services
 224   II,     5.  6.  6    |                     Jamison DT, Murray CJL (2006): Global Burden of Disease
 225   II,     5.  6.  6    |                     URL : ht ~ ~WHO Europe (2006): Gaining Health. The European
 226   II,     5.  6.  6    |                 Copenhagen, 11-14 September 2006. Available at URL: htt ~ ~
 227   II,     5.  6.  6    |                     Woolf AD and Akesson K (2006): The Patient with Osteoporosis.
 228   II,     5.  7.  1    |                   al. 2006b; Cirillo et al, 2006; Van Biesen et al, 2007);
 229   II,     5.  7.  1    |                     Kidney Foundation, 2002-2006; Sarnak et al., 2003; American
 230   II,     5.  7.  1    |              American Diabetes Association, 2006), but this knowledge has
 231   II,     5.  7.  1    |                     2005; Kimmel and Patel, 2006) and in children (McKenna
 232   II,     5.  7.  1    |                    children (McKenna et al, 2006; Fadrowski et al, 2006),
 233   II,     5.  7.  1    |                      2006; Fadrowski et al, 2006), these diseases impose
 234   II,     5.  7.  3    |                    al, 2004; Stewart et al, 2006). The increasing incidence
 235   II,     5.  7.  3    |                      Norway) (Hallan et al, 2006) to 7.2% (Germany) (Meisinger
 236   II,     5.  7.  3    |                  Germany) (Meisinger et al, 2006) in males and from 6.2% (
 237   II,     5.  7.  3    |                      Italy) (Cirillo et al, 2006) to 10.2% (Iceland) (Viktorsdottir
 238   II,     5.  7.  3    |                       Norway (Hallan et al, 2006; Hallan et al, 2006). In
 239   II,     5.  7.  3    |                     al, 2006; Hallan et al, 2006). In all countries where
 240   II,     5.  7.  3    |                  NHANES IV) (Tonelli et al, 2006; Zoccali and DeJong, 2007),
 241   II,     5.  7.  3    |                    al, 2004; Stewart et al, 2006). The increasing incidence
 242   II,     5.  7.  4    |                    obesity (Ejerblad et al, 2006) and perhaps non-traditional
 243   II,     5.  7.  4    |                     oxide synthase (Zoccali 2006) appear to be the main drivers
 244   II,     5.  7.  4    |                    in children (Wang et al, 2006). Since these risk factors
 245   II,     5.  7.  5    |                      2003; Atthobari et al, 2006). Targeting individuals
 246   II,     5.  7.  5    |                     92 dialysis centres; in 2006, there were 464 pmp under
 247   II,     5.  7.  7    |                 Diabetes Association (ADA) (2006): Standards of medical care
 248   II,     5.  7.  7    |                diabetes-2006. Diabetes Care 2006;29:S1-S85.~Annual data report
 249   II,     5.  7.  7    |                    HL, van Gilst WH, et al (2006): Cost-effectiveness of
 250   II,     5.  7.  7    |                 studies. Clin Therapeutics, 2006;28:432-44.~Baigent C, Burbury
 251   II,     5.  7.  7    |                    Lombardi C, De Santo NG (2006): Low glomerular filtration
 252   II,     5.  7.  7    |                   and awareness. Kidney Int 2006 Aug;70(4):800-6.~Coresh
 253   II,     5.  7.  7    |                     McLaughlin JK, Nyren O (2006): Obesity and risk for chronic
 254   II,     5.  7.  7    |                   failure. J Am Soc Nephrol 2006 Jun;17(6):1695-702.~ERA-EDTA
 255   II,     5.  7.  7    |                  Weiss RA, Gerson A, et al (2006): Changes in physical and
 256   II,     5.  7.  7    |                    disease. Pediatr Nephrol 2006 Mar;21(3):394-9.~Gansevoort
 257   II,     5.  7.  7    |                 ESRD risk. J Am Soc Nephrol 2006; 17:2275-84.~Hallan SI,
 258   II,     5.  7.  7    |                sectional health survey. BMJ 2006 Nov 18;333(7577):1047.~Hsu
 259   II,     5.  7.  7    |                    20.~Kimmel PL, Patel SS (2006): Quality of life in patients
 260   II,     5.  7.  7    |                 hemodialysis. Semin Nephrol 2006 Jan;26(1):68-79.~Kurella
 261   II,     5.  7.  7    |                    S, Williams A, Geary DF (2006): Quality of life in children
 262   II,     5.  7.  7    |                     Nephrol Dial Transplant 2006 Jul;21(7):1899-905.~Meisinger
 263   II,     5.  7.  7    |             Meisinger C, Doring A, Lowel H (2006): Chronic kidney disease
 264   II,     5.  7.  7    |                     population. Eur Heart J 2006 May;27(10):1245-50.~National
 265   II,     5.  7.  7    |                    disease. Am J Kidney Dis 2006;47(Suppl 3):S1-S145.~National
 266   II,     5.  7.  7    |                   McCredie MR, Williams SM (2006): Geographic, ethnic, age-related
 267   II,     5.  7.  7    |                     Nephrol Dial Transplant 2006 Aug;21(8):2178-83.~Tonelli
 268   II,     5.  7.  7    |                     Rabbat C, Fok M, et al (2006): Chronic kidney disease
 269   II,     5.  7.  7    |                    review. J Am Soc Nephrol 2006 Jul;17(7):2034-47.~ ~
 270   II,     5.  8.  1    |                  UE-25 (Niederlander et al, 2006). COPD is the main reason
 271   II,     5.  8.  1    |                   and emphysema: (Siafakas, 2006). COPD has significant extra-pulmonary
 272   II,     5.  8.  1    |                   particles or gases (GOLD, 2006).~ ~Exposure to noxious
 273   II,     5.  8.  3    |                    criteria (Lindberg et al 2006). This was significantly
 274   II,     5.  8.  3    |              never-smokers (Pelkonen et al, 2006).~ ~In another study performed
 275   II,     5.  8.  3    |                  for 25 years (Lokke et al, 2006). Abnormal lung function
 276   II,     5.  8.  3    |                   published (Chapman et al, 2006). The variability of prevalence
 277   II,     5.  8.  3    |               meta-analysis (Halbert et al, 2006) estimated a prevalence
 278   II,     5.  8.  3    |                  and 0.3% (Zielinski et al, 2006). People with chronic cough
 279   II,     5.  8.  3    |                severe 0.1%) (Lindberg et al 2006). All subjects with severe
 280   II,     5.  8.  3    |                    declined (Chapman et al, 2006).~ ~Interesting data are
 281   II,     5.  8.  3    |                  COPD (Rea et al 2004; GOLD 2006)~ ~A relevant association
 282   II,     5.  8.  3    |           underlying causes (Furhman et al, 2006). In this study, cardiovascular
 283   II,     5.  8.  3    |                     by Calverley and Scott (2006). The authors stated that,
 284   II,     5.  8.  3    |               Netherlands (Vermeeren et al, 2006). The results showed that
 285   II,     5.  8.  3    |                      10% (Carrasco Garrido, 2006). In a study by Sprenkle
 286   II,     5.  8.  3    |                     compared (Chapman et al 2006). It was shown that the
 287   II,     5.  8.  3    |                    of Dubrovnik during 2002-2006. COPD patients (446) were
 288   II,     5.  8.  4    |              never-smokers (Pelkonen et al, 2006). During the follow-up,
 289   II,     5.  8.  4    |                  for 25 years (Lokke et al, 2006). Abnormal lung function
 290   II,     5.  8.  5    |           panbronchiolitis (Siafakas et al, 2006). For this reason, chest
 291   II,     5.  8.  5    |                   every year by GOLD (GOLD, 2006).~ ~The Global Alliance
 292   II,     5.  8.  7    |                    Calverley PMA, Scott S. (2006): Is Airway Inflammation
 293   II,     5.  8.  7    |               Obstructive Pulmonary Disease 2006; 3: 233-242~ ~Celli BR,
 294   II,     5.  8.  7    |                   242~ ~Celli BR, MacNee W (2006): ATS/ERS Task Force Standards
 295   II,     5.  8.  7    |                     Aldington S, Beasley R (2006): Epidemiology and costs
 296   II,     5.  8.  7    |             pulmonary disease. Eur Respir J 2006; 27: 188-207.~ ~Dal Negro
 297   II,     5.  8.  7    |                     Eilstein D, Delmas M-C (2006): Deaths from chronic obstructive
 298   II,     5.  8.  7    |             multiple cause analysis. Thorax 2006; 61: 930-934.~ ~Geijer RM,
 299   II,     5.  8.  7    |                     Med 102:885-891~ ~GOLD (2006): Global Strategy for the
 300   II,     5.  8.  7    |                  Executive Summary, updated 2006. The Global initiative for
 301   II,     5.  8.  7    |                    co-morbidity. Respir Res 2006; 7: 109-116.~ ~Halbert RJ,
 302   II,     5.  8.  7    |                    E, Buist AS, Mannino DM (2006):Global burden of COPD:
 303   II,     5.  8.  7    |                 meta-analysis. Eur Respir J 2006; 28: 523-532.~ ~Hansell
 304   II,     5.  8.  7    |                    Larsson LG, Lundback B. (2006): Prevalence and underdiagnosis
 305   II,     5.  8.  7    |                  Sweden Studies. Respir Med 2006; 100: 264-272.~ ~Lindberg
 306   II,     5.  8.  7    |                    Sandstrom T, Lundback B (2006): Seven-year cumulative
 307   II,     5.  8.  7    |                    population sample. Chest 2006; 129: 879-885.~ ~Lokke A,
 308   II,     5.  8.  7    |                      Fabricius P, Vestbo J (2006): Developing COPD: a 25
 309   II,     5.  8.  7    |                  general population. Thorax 2006; 61: 935-939.~ ~L J (2006):
 310   II,     5.  8.  7    |                   2006; 61: 935-939.~ ~L J (2006): Global and regional burden
 311   II,     5.  8.  7    |              population health data. Lancet 2006; 367: 1747-1757.~ ~Lundback
 312   II,     5.  8.  7    |                  Martin A, Alvarez-Sala JL (2006): Chronic respiratory symptoms,
 313   II,     5.  8.  7    |              general population. Respir Med 2006; 100: 1973-1980.~ ~Mohangoo
 314   II,     5.  8.  7    |                      Schellevis FG, Raat H (2006): Prevalence estimates of
 315   II,     5.  8.  7    |             difference? Eur J Public Health 2006; 16: 101-105.~ ~Murray CJ,
 316   II,     5.  8.  7    |                     Niederlander E. Health (2006): In “Population and social
 317   II,     5.  8.  7    |                  and social conditions”, 10/2006, Eurostat.~ ~Pelkonen M,
 318   II,     5.  8.  7    |                     Tukiainen H, Koskela H (2006): Thirty-year cumulative
 319   II,     5.  8.  7    |                middle-aged rural men. Chest 2006; 130: 1129-1137.~ ~Rea H,
 320   II,     5.  8.  7    |                   Respir Mon, Monograph 38, 2006; 11: 1-6.~ ~Sidney S, Sorel
 321   II,     5.  8.  7    |                     Roldaan AC, Wouters EF (2006):on behalf of the COSMIC
 322   II,     5.  8.  7    |              patients with COPD. Respir Med 2006; 100: 1349-1355.~ ~Viegi
 323   II,     5.  8.  7    |                     awareness. Eur Respir J 2006; 27: 833-852.~ ~Zock J-P,
 324   II,     5.  9.  1    |                    symptoms (Holgate et al, 2006).~ ~Allergic rhinitis (AR)
 325   II,     5.  9.  1    |                    increase (Holgate et al, 2006). Changes in diagnostic
 326   II,     5.  9.  1    |                daily life (Baiardini et al, 2006).~ ~Understanding asthmatic
 327   II,     5.  9.  3    |                    of Dubrovnik during 2002-2006. Asthma patients (4121)
 328   II,     5.  9.  4    |                PARSIFAL study (Alf T et al, 2006). Growing up on a farm was
 329   II,     5.  9.  4    |                contact eczema) from 2003 to 2006 in a population-based sample
 330   II,     5.  9.  4    |                   bioassays.(Steerenberg PA 2006)~Fine ambient PM exerted
 331   II,     5.  9.  4    |                  Hygiene Hypothesis” (Wang, 2006; von Mutius, 2006; Heinrich
 332   II,     5.  9.  4    |                     Wang, 2006; von Mutius, 2006; Heinrich et al, 2001).~ ~
 333   II,     5.  9.  6    |                   of view (Baiardini et al, 2006). HRQoL is assessed by means
 334   II,     5.  9.  6    |               Asthma (GINA) document (GINA, 2006). Global strategy for asthma
 335   II,     5.  9.  6    |          Respiratory Diseases (GARD) (Bo l, 2006), a WHO initiative aiming
 336   II,     5.  9.  6    |            recommendations (Bousquet et al, 2006). ARIA goals for both specialists
 337   II,     5.  9.  7    |                      References~ ~Alfvén T (2006): Allergic diseases and
 338   II,     5.  9.  7    |                    PARSIFAL study. Allergy. 2006 Apr;61(4):414-21.~ ~Anderson
 339   II,     5.  9.  7    |                      Brandi S, Canonica GW (2006): Allergic diseases and
 340   II,     5.  9.  7    |                     Allergy Asthma Immunol. 2006; 97:419-28~ ~Barnes PJ, Jon B (
 341   II,     5.  9.  7    |                    of asthma. Eur Respir J. 2006 Apr;9(4):636-42~ ~Bj P (
 342   II,     5.  9.  7    |                   Rev 2003; 3:43-45~ ~Bo N (2006): GARD (Global Alliance
 343   II,     5.  9.  7    |               Initiative for Asthma (GINA) (2006): Global strategy for asthma
 344   II,     5.  9.  7    |                     and prevention. Revised 2006~ ~Masoli M, Fabian D, Holt
 345   II,     5.  9.  7    |                   ST, Price D, Valovirta E (2006): Asthma out of control?
 346   II,     5.  9.  7    |                      BMC Pulmonary Medicine 2006, 6(Suppl 1):S2 doi:10.1186/
 347   II,     5.  9.  7    |                     116:675-682).~ ~Keil T (2006): European birth cohort
 348   II,     5.  9.  7    |                  GA2LEN initiative. Allergy 2006;61:221-228~ ~Kim DS, Drake-Lee
 349   II,     5.  9.  7    |                     6):1232-8~ ~von Mutius (2006): The PASTURE project: EU
 350   II,     5.  9.  7    |                    atopy in Europe. Allergy 2006;61:407-413~ ~Vrbica  (2007):
 351   II,     5.  9.  7    |                    hr~ ~Wang Y, McCusker C (2006): Neonatal exposure with
 352   II,     5.  9.  7    |                     J Allergy Clin Immunol. 2006 Jul;118(1):143-51. Epub
 353   II,     5.  9.  7    |                     Jul;118(1):143-51. Epub 2006 May 19.~ ~World Health Organization (
 354   II,     5. 10.  1    |                     EFSA, 2004 and INFOSAN, 2006)~ ~ ~ ~Up to 18% of the
 355   II,     5. 10.  1    |                     The InformALL database, 2006), although few foods are
 356   II,     5. 10.  2    |                     al, 2003; Gendel et al, 2006). The design, structure,
 357   II,     5. 10.  2    |                age-dependant (DunnGalvin A, 2006). In addition, most of the
 358   II,     5. 10.  6    |                 modified organisms, Taylor, 2006; Thomas et al, 2007).~ ~
 359   II,     5. 10.  7    |                     Elberink JNG, Klinge I (2006): Incorporating a gender
 360   II,     5. 10.  7    |                      Gendel SM, Jenkins JA (2006): Allergen sequence databases.
 361   II,     5. 10.  7    |              Authorities Network (INFOSAN) (2006): INFOSAN information note
 362   II,     5. 10.  7    |              INFOSAN information note No. 3/2006- Food Allergies. World Health
 363   II,     5. 10.  7    |                 Health Organization, 9 June 2006. htt ~ ~Knibb RC, Booth
 364   II,     5. 10.  7    |                  Allergy 56: 91-102.~Tay L (2006): Review of the development
 365   II,     5. 11.  3    |          dermatologic care (Williams et al, 2006).~ ~Skin diseases are a
 366   II,     5. 11.  3    |                    in Europe Eur J Dermatol 2006;16:212-218~ ~ ~Table 5.11.
 367   II,     5. 11.  7    |                  Grob JJ, Bouwes Bavick JN (2006): Epidemiology of skin diseases
 368   II,     5. 11.  7    |                    in Europe Eur J Dermatol 2006:16:212-218.~ ~ ~ ~
 369   II,     5. 12.  1    |             Scotland (Leon and McCambridge, 2006).~In order to monitor recent
 370   II,     5. 12.  4    |          populations (Leon and McCambridge, 2006). Although there are suggestions
 371   II,     5. 12.  7    |                     Leon DA, McCambridge J (2006): Liver cirrhosis mortality
 372   II,     5. 15.  3    |                    et al, 2007; Dear et al, 2006; Kesselman et al, 2006;
 373   II,     5. 15.  3    |                      2006; Kesselman et al, 2006; Aronson, 2006; Haffner,
 374   II,     5. 15.  3    |             Kesselman et al, 2006; Aronson, 2006; Haffner, 2006; Clarke,
 375   II,     5. 15.  3    |                     Aronson, 2006; Haffner, 2006; Clarke, 2006; McCabe, 2005).
 376   II,     5. 15.  3    |                      Haffner, 2006; Clarke, 2006; McCabe, 2005). Currently
 377   II,     5. 15.  4    |                  collected was published in 2006 (European Commission, 2006).
 378   II,     5. 15.  4    |                  2006 (European Commission, 2006). This second publication
 379   II,     5. 15.  4    |              Demonstration Activities (2002-2006) has included among its
 380   II,     5. 15.  6    |                     18.04.2008).~Clarke JT (2006): Is the current approach
 381   II,     5. 15.  6    |                   drug review policy. CMAJ. 2006 Jan 17;174(2):189-90.~Dear
 382   II,     5. 15.  6    |                  Lilitkarntakul P, Webb DJ (2006): Are rare diseases still
 383   II,     5. 15.  6    |               products. Br J Clin Pharmacol 2006, 62:3, 264-271.~Drummond
 384   II,     5. 15.  6    |                     42~European Commission (2006): Inventory of Community
 385   II,     5. 15.  6    |                     12.05.2007)~Haffner ME (2006): Adopting orphan drugs --
 386   II,     5. 15.  6    |                rare diseases. N Engl J Med. 2006 Feb 2;354(5):445-7.~Holzman
 387   II,     5. 15.  6    |                      Chertkoff R, Zimran A (2006): National health budgets
 388   II,     5. 15.  6    |                 model. Blood Cells Mol Dis. 2006 Jul-Aug;37(1):46-9. Epub
 389   II,     5. 15.  6    |                    Jul-Aug;37(1):46-9. Epub 2006 Jul 7.~McCabe C, Claxton
 390   II,     5. 15.  6    |                 orphan drugs. J Intern Med. 2006; 260(1):1-10.~ ~ ~
 391   II,     6.  3.  3    |                 through the introduction in 2006 of a vaccine, but is not
 392   II,     7.  1        |        Communication from the Commission of 2006. In order to assist national
 393   II,     7.  4.  1    |              practice guide” (MacKay et al, 2006), and is providing materials
 394   II,     7.  4.  5    |        Community-wide (European Commission, 2006).~ ~Valuable information
 395   II,     7.  4.  6    |                  area (European Commission, 2006).~ ~In the general school
 396   II,     7.  4.  7    |               society (European Commission, 2006).~ ~No single factor explains
 397   II,     7.  5        |                      compare Shields et al, 2006). Other areas that are less
 398   II,     7.  5        |                 safer Europe” from June 23, 2006, developed by DG Sanco together
 399   II,     7.  5        |                States (European Commission, 2006). The Communication informs
 400   II,     7.  5        |                    the WHO (Schopper et al, 2006). This guideline conceptualises
 401   II,     7.  7        |                     Freizeitunfallstatistik 2006. Vienna, Kuratorium für
 402   II,     7.  7        |                        European Commission (2006): Communication from the
 403   II,     7.  7        |                     for a safer Europe. COM/2006/0328 of June 23, 2006 (CELEX-Nr.
 404   II,     7.  7        |                   COM/2006/0328 of June 23, 2006 (CELEX-Nr. 52006DC0328).~ ~
 405   II,     7.  7        |                    J, Brussoni M, Towner L (2006): Child Safety Good Practice
 406   II,     7.  7        |                     JD, Waxweiler R (Eds.) (2006): Developing policies to
 407   II,     7.  7        |                    Aguirre I, Baumgarten I (2006): National responses to
 408   II,     8.  1.  4    |         developments~ ~EUROSTAT launched in 2006 a project, with the aim
 409   II,     8.  1.  5(3) |                  Assembly on 13 of December 2006.~
 410   II,     8.  1.  5    |                   phase of the Action Plan (2006-2007)6 focused on the active
 411   II,     8.  2.  1    |                     following the Census of 2006, and preliminary results
 412   II,     8.  2.  1    |                     two Interim Reports for 2006 and 2007 that can be found
 413   II,     8.  2.  1    |                  and care. As Cooper et al (2006) note, regular health screening
 414   II,     8.  2.  1    |                Martin, G. and Robinson, N. (2006). Improving the health of
 415   II,     8.  2.  1    |                  121~Pezzementi and Fisher (2006). Oral health status of
 416   II,     8.  2.  1    |                     57:64-66.~Stegeman, I. (2006). Health Inequalities in
 417   II,     8.  2.  2    |                 health-care systems. In May 2006, the World Health Assembly
 418   II,     8.  2.  2    |                     BLINDNESS - ACTION PLAN 20062011highlights the main
 419   II,     8.  2.  2    |                    World Health Assembly in 2006.~ ~
 420   II,     8.  2.  2    |            avoidable blindness, action plan 2006 - 2011. Available online
 421   II,     9            |                   et al, 1994; Reddy et al, 2006). Studies report higher
 422   II,     9            |                     anomalies (Botto et al, 2006). Other nutrients are most
 423   II,     9            |                      2004; Macintosh et al, 2006), and there is increasing
 424   II,     9            |                   of care (Macintosh et al, 2006). The rising prevalence
 425   II,     9            |                   adulthood (Michels et al, 2006)~ ~Current EU environments
 426   II,     9.  1.  1    |                 term babies (Escobar et al, 2006; Kramer et al, 2000a; Marret
 427   II,     9.  1.  1    |                decade (Langhoff-Ross et al, 2006); these trends, which cannot
 428   II,     9.  1.  1    |                     M, Breart G, Zeitlin J (2006): Preterm birth and multiple
 429   II,     9.  1.  1    |                  the PERISTAT project. Bjog 2006;113(5):528-35.~ ~Bouvier-Colle
 430   II,     9.  1.  1    |                    GJ, Clark RH, Greene JD (2006): Short-term outcomes of
 431   II,     9.  1.  1    |                  questions. Semin Perinatol 2006;30(1):28-33.~ ~EUROSTAT
 432   II,     9.  1.  1    |                   EUROSTAT DATABASE. htt nd 2006;accessed January 2008.~ ~
 433   II,     9.  1.  1    |                    B, Rasmussen S, Vogel I (2006): Spontaneous preterm delivery
 434   II,     9.  1.  1    |                 population based study. Bmj 2006;332(7547):937-9.~ ~Lin HC,
 435   II,     9.  1.  1    |                     UM, Ko CW, Willinger M (2006): Maternal age and the risk
 436   II,     9.  1.  1    |                 States. Am J Obstet Gynecol 2006;195(3):764-70.~SCPE (Surveillance
 437   II,     9.  1.  2    |                   exposures (Bianchi et al, 2006).~ ~
 438   II,     9.  1.  2    |                   et al, 1994; Reddy et al, 2006). Studies report higher
 439   II,     9.  1.  2    |                     anomalies (Botto et al, 2006). Other nutrients are most
 440   II,     9.  1.  2    |                      2004; Macintosh et al, 2006), and there is increasing
 441   II,     9.  1.  2    |                   of care (Macintosh et al, 2006). The rising prevalence
 442   II,     9.  1.  2    |                anomalies also (Botto et al, 2006) by raising the folate status
 443   II,     9.  1.  2    |                 Stoll C and Mastroiacovo P (2006): "Trends of Selected Malformations
 444   II,     9.  1.  2    |                Fleming KM, Bailey JA et al (2006): Perinatal mortality and
 445   II,     9.  1.  2    |                population-based study. BMJ. 2006 July 22; 333(7560): 177.~
 446   II,     9.  2.  3    |                 2003), although in November 2006 the UK Health Protection
 447   II,     9.  2.  3    |                 1996 to 3 000 in 2005) (HPA 2006). However, trends in fluctuation
 448   II,     9.  2.  3    |                 Lobstein and Jackson-Leach, 2006)).~ ~The World Health Organisation
 449   II,     9.  2.  3    |                     is so concerned that in 2006 it organised a conference
 450   II,     9.  2.  6    |                   the Finnish Presidency in 2006 (Ståhl et al, 2006; Council
 451   II,     9.  2.  6    |            Presidency in 2006 (Ståhl et al, 2006; Council of the European
 452   II,     9.  2.  6    |              Council of the European Union, 2006), and through the Rome Ministerial
 453   II,     9.  2.  7    |              Council of the European Union (2006): Council Conclusions on
 454   II,     9.  2.  7    |                Network-UN Meeting Florence (2006): Promoting Healthy Lives
 455   II,     9.  2.  7    |                    Rights of the ChildCOM(2006) 367 final. Available at:~htt ~ ~
 456   II,     9.  2.  7    |                    of Commitments. 29 March 2006. http://ec.europa.eu/health/
 457   II,     9.  2.  7    |                   No. 246 p 13. 9 November, 2006~ ~European Commission (2007):
 458   II,     9.  2.  7    |                    Protection Agency (HPA) (2006): A complex PictureHIV
 459   II,     9.  2.  7    |                     hpa.org.uk/publications/2006/hiv_sti_2006/pdf/keypoints_
 460   II,     9.  2.  7    |                   publications/2006/hiv_sti_2006/pdf/keypoints_recommend.
 461   II,     9.  2.  7    |                 Lahtinen E, Leppo K (eds.) (2006): Health in All Policies –
 462   II,     9.  2.  7    |                    12 September 2005~ ~WHO (2006) Regional Office for Europe:
 463   II,     9.  3.  1    |                     in men (White & Holmes, 2006). Apart from very few male
 464   II,     9.  3.  1    |                    country (White & Holmes, 2006). It can be argued that
 465   II,     9.  3.  1    |                     females (Niederlaender, 2006). This greater risk of road
 466   II,     9.  3.  1    |                     and Latvia (WHO HFA-DB, 2006).~ ~Mental health, psychiatric
 467   II,     9.  3.  1    |             behaviour and self harm (White, 2006). This is coupled with the
 468   II,     9.  3.  1    |                   higher among women (EIWH, 2006). Depression is the main
 469   II,     9.  3.  1    |               testing and treatment (Arber, 2006).~ ~Because CVD tends to
 470   II,     9.  3.  1    |                     European Heart Network, 2006). Hormonal balance associated
 471   II,     9.  3.  1    |               population) (White and Homes, 2006). A similar pattern was
 472   II,     9.  3.  1    |              vasculature (White and Holmes, 2006).~ ~The main circulatory
 473   II,     9.  3.  1    |                   EU27 average (WHO HFA-DB, 2006).~ ~Stroke. Stroke is an
 474   II,     9.  3.  1    |                   24 years of age (EuroHIV, 2006). In many societies, it
 475   II,     9.  3.  1    |                   Slovenia and the UK (WHO, 2006). In November 2006, the
 476   II,     9.  3.  1    |                     WHO, 2006). In November 2006, the UK Health Protection
 477   II,     9.  3.  1    |                 1996 to 3 000 in 2005 (HPA, 2006). Trends in fluctuation
 478   II,     9.  3.  1    |               Clinical Practice Guidelines (2006) suggest a repeated level <
 479   II,     9.  3.  1    |                   adulthood (Michels et al, 2006)~ ~Current EU environments
 480   II,     9.  3.  1    |                McKinlay J, Adams A, et al, (2006): Patient characteristics
 481   II,     9.  3.  1    |             European Commission.~ ~EuroHIV (2006) : HIV/AIDS Surveillance
 482   II,     9.  3.  1    |           Luxembourg~ ~European Commission (2006): Report on Equality between
 483   II,     9.  3.  1    |                  figures: Eurostat yearbook 2006-07. Luxembourg: Office for
 484   II,     9.  3.  1    |                  Publishing, Oxford.~ ~HPA (2006): ht m (Article online,accessed
 485   II,     9.  3.  1    |                  Equality Policy. Helsinki (2006): 112 pp. (Publications
 486   II,     9.  3.  1    |                    Terry KL and Willett WC (2006): Longitudinal Study on
 487   II,     9.  3.  1    | 1992Impotence091html.htm~ ~Niederlaender E (2006): Causes of death in the
 488   II,     9.  3.  1    |                    And Social Conditions 10/2006~ ~Plümper T, Neumayer E (
 489   II,     9.  3.  1    |                      Plümper T, Neumayer E (2006): The unequal burden of
 490   II,     9.  3.  1    |                    57(1):48-52.~ ~White AK (2006): Men and mental wellbeing:
 491   II,     9.  3.  1    |                    7~ ~White AK, Holmes M, (2006): Patterns of mortality
 492   II,     9.  3.  1    |             epidemic http / (accessed April 2006)~ ~WHO (2006): European
 493   II,     9.  3.  1    |                 accessed April 2006)~ ~WHO (2006): European Charter on counteracting
 494   II,     9.  3.  1    |              counteracting obesity November 2006 http 1 (Article online,
 495   II,     9.  3.  1    |                      accessed 07.07)~ ~WHO (2006): European Ministerial Conference
 496   II,     9.  3.  1    |             Counteracting Obesity: November 2006 http f (Article online,
 497   II,     9.  3.  1    |               accessed 07.07)~ ~WHO HFA-DB (2006): Health for All Database: htt / (
 498   II,     9.  3.  2    |                    France (Philibert et al, 2006) or the Netherlands (van
 499   II,     9.  3.  2    |                  EUGLOREH countries in 2004-2006~ ~For a few countries -
 500   II,     9.  3.  2    |            post-term births (Blondel et al, 2006; Zeitlin et al, 2007). Similarly,